Riskpilot← Back to searchSign inGet full accessSwedish Pharma Nutrition AB
ABActiveOrg 5593547606Färsnagatan 10 COther non-specialised retail sale · NACE 4712Est. 20210 employees
Revenue 2025
SEK 34K
+41% vs 2024
EBITDA margin
-195.3%
-6254% vs 2024
Equity ratio
23.3%
Financial strength
Net profit 2025
SEK -64K
-5974% vs 2024
| Revenue | SEK 34K | +41% |
| EBITDA | SEK -67K | -6254% |
| Net profit | SEK -64K | -5974% |
| Total assets | SEK 155K | +658% |
| Equity | SEK 36K | +77% |
| Employees | 0 | — |
Legal name
Swedish Pharma Nutrition AB
Org number
5593547606
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
17 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva försäljning av kosttillskott, träningskläder och andra idrottsartiklar genom e-handel samt återförsäljare.
Address
Färsnagatan 10 C
Email
berkanzs@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 128 | 65 | 24 | 34 |
| Staff expenses | — | — | — | — |
| EBITDA | −15 | −6 | 1 | −67 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | −15 | −6 | 1 | −56 |
| Net financials | — | — | — | 0 |
| Profit before tax | −15 | −6 | 1 | −64 |
| Tax | −0 | — | — | — |
| Net profit | −15 | −6 | 1 | −64 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 10 | 19 | 20 | 155 |
| Equity | 10 | 19 | 20 | 36 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 0 | — | — | 119 |
| Total debt | — | — | — | 119 |
EBITDA margin
-195.3%
This company
15.8%
Market median
-1336% vs market
20222025
Equity ratio
23.3%
This company
38.2%
Market median
-39% vs market
20222025
Return on equity
-177.4%
This company
18.4%
Market median
-1064% vs market
20222025
Net profit margin
-186.4%
This company
8.1%
Market median
-2401% vs market
20222025
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20222025
Debt / equity
3.29×
This company
0.62×
Market median
-431% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Swedish Pharma Nutrition AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jennifer M S Berzén Lundberg | Deputy Board Member | 0 companies |
| Heinz Klostermann | Board of Directors | 0 companies |
| Victor Mikael Berzén Lundberg | Board of Directors | 0 companies |
| Måns Erik Heinz Klostermann | Deputy Board Member | 0 companies |
| Elliot Carl Viktor Strokirk | Chairman | 0 companies |